Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BEVACIZUMAB Cause Blood creatinine increased? 551 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 551 reports of Blood creatinine increased have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 0.7% of all adverse event reports for BEVACIZUMAB.

551
Reports of Blood creatinine increased with BEVACIZUMAB
0.7%
of all BEVACIZUMAB reports
93
Deaths
251
Hospitalizations

How Dangerous Is Blood creatinine increased From BEVACIZUMAB?

Of the 551 reports, 93 (16.9%) resulted in death, 251 (45.6%) required hospitalization, and 17 (3.1%) were considered life-threatening.

Is Blood creatinine increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB. However, 551 reports have been filed with the FAERS database.

What Other Side Effects Does BEVACIZUMAB Cause?

Off label use (12,094) Death (8,493) Diarrhoea (4,911) Disease progression (4,653) Fatigue (4,572) Nausea (4,357) Hypertension (4,309) Anaemia (3,221) Vomiting (3,193) Neutropenia (2,875)

What Other Drugs Cause Blood creatinine increased?

EMTRICITABINE\TENOFOVIR DISOPROXIL (1,966) TENOFOVIR DISOPROXIL (1,460) TACROLIMUS (1,439) METHOTREXATE (1,401) SACUBITRIL\VALSARTAN (1,389) RITUXIMAB (1,265) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (1,112) METFORMIN (986) ECULIZUMAB (967) LENALIDOMIDE (959)

Which BEVACIZUMAB Alternatives Have Lower Blood creatinine increased Risk?

BEVACIZUMAB vs BEVACIZUMAB-AWWB BEVACIZUMAB vs BEVACIZUMAB-BVZR BEVACIZUMAB vs BEVACIZUMAB-MALY BEVACIZUMAB vs BEXAROTENE BEVACIZUMAB vs BEYAZ

Related Pages

BEVACIZUMAB Full Profile All Blood creatinine increased Reports All Drugs Causing Blood creatinine increased BEVACIZUMAB Demographics